Letrozole/Palbociclib Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C142859
A chemotherapy regimen consisting of letrozole and palbociclib that is used as a treatment for estrogen receptor (ER)-positive and HER-2/neu-negative metastatic or advanced breast cancer. [ ]
Term info
Label
Letrozole/Palbociclib Regimen
Synonyms
- Femara/Ibrance
- Letrozole + Palbociclib
- Letrozole-Palbociclib
- Letrozole/Palbociclib
- Letrozole/Palbociclib Regimen
- Palbociclib + Letrozole
Subsets
NCIT_C160952, NCIT_C160950, NCIT_C116978, NCIT_C116977
Contributing Source
CTRP
Display Name
Letrozole/Palbociclib Regimen
NCI META CUI
CL540744
PDQ Closed Trial Search ID
791794
PDQ Open Trial Search ID
791794
Preferred Name
Letrozole/Palbociclib Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C142859